Items Tagged with 'cannabis'

ARTICLES

RESEARCH UPDATE

Driving Performance and Cannabis Users’ Perception of Safety: A Randomized Trial

January 30, 2023
Olaniyi Olayinka, MD.

Olaniyi Olayinka, MD. Dr. Olayinka has no financial relationships with companies related to this material.

Everyone knows that drinking alcohol can impair driving ability. Researchers here demonstrate that driving under the influence of cannabis can be risky as well.


Read More
EXPERT Q&A

Medicinal Cannabis

September 1, 2022
Deepak Cyril D’Souza, MD

Deepak Cyril D’Souza, MD. Professor of Psychiatry, Yale University School of Medicine. Psychiatrist, VA Connecticut Healthcare System, New Haven, CT. Dr. D’Souza, expert for this educational activity, has disclosed that he owns stocks in Jazz Pharmaceuticals and Biohaven Pharmaceuticals. Dr. Capurso has reviewed the content of this interview and determined that there is no commercial bias as a result of these financial relationships.

Laws permitting the use of cannabis for medicinal purposes are being passed around the country, but what are we to make of this new and evolving legal patchwork? Dr. D’Souza describes the process and implications of state-specific legislation, and reviews the evidence, or lack thereof, for cannabis treatment of psychiatric disorders.


Read More
EXPERT Q&A

Cannabis Use Disorder and Withdrawal

September 1, 2022
Denise Walker, PhD

Denise Walker, PhD. Research Professor and Director of the Innovative Programs Research Group, School of Social Work, University of Washington, Seattle, WA. Co-developer of The Change Companies’ What About Marijuana Journal. Dr. Walker, expert for this educational activity, has no relevant financial relationship(s) with ineligible companies to disclose.

Dr. Walker reviews the clinical features of cannabis use disorder, who is most at risk, how it is similar and how it differs from other addictions, and treatment approaches. She also describes cannabis withdrawal, a syndrome that can pose a barrier to treatment, but frequently goes unrecognized.


Read More
CLINICAL UPDATE

Currently Available Cannabis Products

September 1, 2022
Alex K. Rahimi, MD

Alex K. Rahimi, MD. Addiction Psychiatrist, Fort Belvoir Community Hospital, VA. Assistant Professor of Psychiatry, Uniformed Services University, Bethesda, MD. Dr. Rahimi, author for this educational activity, has no relevant financial relationship(s) with ineligible companies to disclose.

The sale of medical and recreational cannabis products has become big business as the prevalence of cannabis use increases across the country. There has been an explosion in the number of available products and their potency. Here, we go over what sorts of products are on the market now and what the implications for our patients.


Read More

An Off-Label Guide to Gabapentin

January 31, 2022
Rajesh R. Tampi, MD, MS, DFAPA. and Chris Aiken, MD.
Rajesh R. Tampi, MD, MS, DFAPA. Professor of Medicine, Case Western Reserve University. Chairman, Department of Psychiatry & Behavioral Sciences, Cleveland Clinic Akron General, and Chief of Geriatric Psychiatry, Cleveland Clinic. Chris Aiken, MD. Editor-in-Chief of TCPR. Practicing psychiatrist, Winston-Salem, NC. The authors have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Off-label gabapentin (Neurontin) got a bad rep when it missed the mark in bipolar disorder, but there may be something worth salvaging in this drug. Here, we weigh its pros and cons for anxiety, substance use disorders, sleep, pain, and hot flashes, and compare it to its underutilized cousin, pregabalin (Lyrica).
Read More

Nicotine Patch for Cannabis Withdrawal?

July 3, 2021
John O’Neal, MD.
John O’Neal, MD. Dr. O’Neal has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.
As cannabis use becomes more widespread, treaters will inevitably see increases in patients reporting symptoms of cannabis withdrawal. Researchers in this study investigated whether a nicotine patch might help mitigate some of these symptoms. Results were not particularly promising, and should only be considered for patients who also use tobacco.
Read More

Cannabis and Kids

December 16, 2019
Child psychiatrists are grappling with the problem of pervasive use of marijuana in an age where legalization of use for adults has led to even greater use in teens. In this episode, Dr. Feder and Mara go over two recent interviews in The Carlat Child Psychiatry Report with Gabriella Gobbi, MD, PhD, of...
Read More

Outpatient Management of Opioid Addiction

October 3, 2019
Sandra Gomez-Luna, MD
Sandra Gomez-Luna, MDSandra Gomez-Luna, MD

Child, adolescent, and adult psychiatrist in Darien, CT. Medical Director of Parent Child Support Center, a subsidiary of Behavioral Health Care (BHcare)

Dr. Gomez-Luna has disclosed that she has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

The opioid crisis demands that child psychiatrists understand more about outpatient treatment in adolescents as more of us are asked to participate in assessment and treatment planning for this population. In this QA, we discuss some of the well-laid-out approaches for child psychiatrists to manage opioid treatment within the child or teen’s community.
Read More

Assessing and Treating Cannabis Use Disorder

October 3, 2019
Gabriella Gobbi, MD, PhD
Gabriella Gobbi, MD, PhDGabriella Gobbi, MD, PhD

Professor, Department of Psychiatry, McGill University; Psychiatrist and Clinical Scientist at the McGill University Health Center

Dr. Gobbi has disclosed that she has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Child psychiatrists are grappling with the problem of pervasive use of marijuana in an age where legalization of use for adults has led to even greater use in teens. In this QA, we discuss the impact of cannabis, its interaction with depression, and the conundrum of cannabis withdrawal so that child psychiatrists can gain tools for addressing marijuana use and addiction in their outpatient practice.
Read More

Motivational Interviewing With Teens About Weed

October 3, 2019
Elizabeth D’Amico, PhD
Elizabeth D’Amico, PhDElizabeth D’Amico, PhD

Senior Behavioral Scientist at RAND and member of the Motivational Interviewing Network of Trainers (MINT)

Dr. D’Amico has disclosed that she has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Child psychiatrists can learn and use motivational interviewing to help teens across a range of substance use disorders. In this QA we cover the efficacy, training and implementation of outpatient motivational interviewing for marijuana and other substance use with teens.
Read More
Share Your Clinical Interests

Completing this brief survey will help us send you materials relevant to your practice.

Take The Survey
Free Psychiatry Updates
The latest unbiased psychiatric information sent to your inbox.
Specify Your Interests
Featured Book
Featured Video
Featured Podcast
Recommended

About

Shop Online

Newsletters

Contact

info@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2023 Carlat Publishing, LLC and Affiliates, All Rights Reserved.